These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 177873)

  • 1. Radiation and high-dose metronidazole in supratentorial glioblastomas.
    Urtasun R; Band P; Chapman JD; Feldstein ML; Mielke B; Fryer C
    N Engl J Med; 1976 Jun; 294(25):1364-7. PubMed ID: 177873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial: Hypoxic cell radiosensitizers.
    Belli JA; Hellman S
    N Engl J Med; 1976 Jun; 294(25):1399-400. PubMed ID: 177876
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiation plus metronidazole for glioblastoma.
    Urtasun RC; Band PR; Chapman JD; Feldstein ML
    N Engl J Med; 1977 Mar; 296(13):757. PubMed ID: 190541
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of hypoxic radiosensitizer sodium glycididazole on long-term result of radiotherapy for nasopharyngeal carcinoma].
    Liu MZ; He LR; Lu TX; Chen YY; Hu YH; Cui NJ; Xu GZ; Gao L; Xiao GL; Zhang SW; Cai Y; Li DM; Chen LH; Wang FY; Sun Q; Zhu L; Sheng G; Gao HJ; Bao YH
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):932-7. PubMed ID: 17533747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme.
    Singh D; Banerji AK; Dwarakanath BS; Tripathi RP; Gupta JP; Mathew TL; Ravindranath T; Jain V
    Strahlenther Onkol; 2005 Aug; 181(8):507-14. PubMed ID: 16044218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase 1 study of high-dose metronidazole: a specific in vivo and in vitro radiosensitizer of hypoxic cells.
    Urtasun RC; Chapman JD; Band P; Rabin HR; Fryer CG; Sturmwind J
    Radiology; 1975 Oct; 117(1):129-33. PubMed ID: 1162051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiation and combined treatment of anaplastic neuroepithelial neoplasms].
    Ragaĭshene VN; Iuozaĭtite EV
    Med Radiol (Mosk); 1989 Dec; 34(12):30-6. PubMed ID: 2601590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic effect on glioblastoma of chemotherapy on the basis of brain irradiation].
    Qin D; Mo H; Ou G
    Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):168-9. PubMed ID: 11783028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation and nitroimidazoles in supratentorial high grade gliomas: a second clinical trial.
    Urtasun R; Feldstein ML; Partington J; Tanasichuk H; Miller JD; Russell DB; Agboola O; Mielke B
    Br J Cancer; 1982 Jul; 46(1):101-8. PubMed ID: 6285947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710.
    Colman H; Berkey BA; Maor MH; Groves MD; Schultz CJ; Vermeulen S; Nelson DF; Mehta MP; Yung WK;
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):818-24. PubMed ID: 16887285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxic cell radiosensitizers in the treatment of malignant brain tumors.
    Gutin PH; Wara WM; Phillips TL; Wilson CB
    Neurosurgery; 1980 May; 6(5):567-76. PubMed ID: 6251398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy with VM 26 and CCNU after operation and radiotherapy of high-grade supratentorial astrocytomas.
    Seiler RW; Zimmermann A; Markwalder H
    Surg Neurol; 1980 Jan; 13(1):65-8. PubMed ID: 6244679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma.
    Geng L; Shinohara ET; Kim D; Tan J; Osusky K; Shyr Y; Hallahan DE
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):263-71. PubMed ID: 16274936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxic sensitizers--implications for radiation therapy.
    Chapman JD
    N Engl J Med; 1979 Dec; 301(26):1429-32. PubMed ID: 229413
    [No Abstract]   [Full Text] [Related]  

  • 17. Open-label simultaneous radio-chemotherapy of glioblastoma multiforme with topotecan in adults.
    Gross MW; Altscher R; Brandtner M; Haeusser-Mischlich H; Chiricuta IC; Siegmann AD; Engenhart-Cabillic R
    Clin Neurol Neurosurg; 2005 Apr; 107(3):207-13. PubMed ID: 15823676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of nitroimidazole and photochemotherapy on solid Ehrlich carcinomas.
    König K; Bockhorn V
    Radiobiol Radiother (Berl); 1989; 30(6):535-9. PubMed ID: 2608894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of electron acceptor compounds in radiotherapy].
    Tsyb AF; Konopliannikov AG; Kudriavtseva GT
    Med Radiol (Mosk); 1983 Jul; 28(7):26-9. PubMed ID: 6348457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
    Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE
    Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.